Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HORIZON: p-HIPEC for Prevention of Peritoneal Recurrence in Gastric Cancer
NCT07139951Phase 2Enrolling by invitation
- Sponsor
- Mayo Clinic
- Start
- Dec 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, paclitaxel in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Mayo Clinic. Started Dec 2025; status: enrolling by invitation.
02
Drugs
cisplatinpaclitaxel
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT07139951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07139951.